Long-term immune response to yellow fever vaccination in human immunodeficiency virus (HIV)–infected individuals depends on HIV RNA suppression status: Implications for vaccination schedule
Clinical Infectious Diseases Mar 25, 2018
Veit O, et al. - In human immunodeficiency virus (HIV)–infected individuals, the immune response over time to yellow fever vaccination (YFV) and the necessity for booster vaccination were investigated. The control of HIV replication at the time of vaccination was primarily influencing HIV-infected patients’ long-term immune response up to 10 years to YFV. Patients with successful combination antiretroviral therapy (cART) showed immune response up to 10 years similar to that of non-HIV-infected adults. A single YFV booster after 10 years was recommended for patients vaccinated on successful cART. However, an early booster might be required in those vaccinated with uncontrolled HIV RNA.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries